P/E ratio for Assurant (AIZ)
P/E ratio as of May 2024 (TTM): 17.8
According to Assurant's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 17.8152. At the end of 2022 the company had a P/E ratio of 24.8.
P/E ratio history for Assurant from 2004 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 24.8 | 268.4% |
| 2021 | 6.74 | -65.2% |
| 2020 | 19.4 | -13.47% |
| 2019 | 22.4 | 4.04% |
| 2018 | 21.5 | 102.12% |
| 2017 | 10.6 | 3.55% |
| 2016 | 10.3 | -73.34% |
| 2015 | 38.5 | 266.04% |
| 2014 | 10.5 | 1.04% |
| 2013 | 10.4 | 69.65% |
| 2012 | 6.14 | -16.09% |
| 2011 | 7.32 | -52.12% |
| 2010 | 15.3 | 88.74% |
| 2009 | 8.10 | 2.05% |
| 2008 | 7.94 | -35.23% |
| 2007 | 12.3 | 25.52% |
| 2006 | 9.76 | -20.77% |
| 2005 | 12.3 | 2.43% |
| 2004 | 12.0 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Aflac AFL | 11.4 | -35.89% | 🇺🇸 USA |
 The Hartford HIG | 13.8 | -22.64% | 🇺🇸 USA |
 MetLife MET | 26.7 | 49.99% | 🇺🇸 USA |
 Principal PFG | 12.5 | -29.81% | 🇺🇸 USA |
 Unum UNM | 8.46 | -52.53% | 🇺🇸 USA |
 UnitedHealth UNH | 22.3 | 25.42% | 🇺🇸 USA |
 CNO Financial Group
CNO | 14.9 | -16.21% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.